Redmile Group, LLC Oncology Institute, Inc. Transaction History

Redmile Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.48 - $1.7 $607,236 - $2.15 Million	-1,265,076 Reduced 79.91%	318,082 $216,000
Q3 2022 Nov 14, 2022	SELL	$0.71 - $7.4 $108,600 - $1.13 Million	-152,958 Reduced 8.81%	1,583,158 $7.33 Million
Q2 2022 Aug 15, 2022	SELL	$4.78 - $9.89 $3.24 Million - $6.71 Million	-678,316 Reduced 28.09%	1,736,116 $8.79 Million
Q1 2022 May 16, 2022	SELL	$3.97 - $9.85 $339,704 - $842,844	-85,568 Reduced 3.42%	2,414,432 $17.2 Million
Q4 2021 Feb 14, 2022	BUY	$6.15 - $10.98 $15.4 Million - $27.5 Million	2,500,000 New	2,500,000 $24.4 Million

12.5M

Ticker TOI
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 73,495,504
Market Cap $39M
Description
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.